Northwestern University researchers have reported that levetiracetam, a long-established anti-epileptic medicine, prevented ...
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
Neurophet AQUA AD Plus quantitatively analyses MRI and PET scans to inform therapy eligibility, monitor treatment-related ...
A new Harvard study shows how lithium, one of the simplest elements, may protect against and even reverse Alzheimer’s — and what that could mean for your brain.
When Staci Marklin was only 43, she began noticing symptoms that didn't align with her previously hyper-organized and meticulous mind which lead a shocking diagnosis.
By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.
We are truly in a new era. We have opened the door to understanding and manipulating the biology of Alzheimer's disease for the benefit of our patients," NEWARK, DE / ACCESS Newswire / February 12, ...
The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.
While physicians and scientists have long known Alzheimer's disease involves the buildup of toxic protein fragments in the ...
Scientists at Northwestern University say a common anti-seizure medication may be able to prevent the earliest steps of Alzheimer’s disease—long before memory loss begins. In a study published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results